Site search
3045 results for '' found
A phase Ib/II open-label, multi-center study of the DNA protein kinase inhibitor AMO959 with lutetium [177Lu] vipivotide tetraxetan [AAA617] in combination with an androgen receptor pathway inhibitor
A phase Ib/II open-label, multi-center study of the DNA protein kinase inhibitor AMO959 with lutetium [177Lu] vipivotide tetraxetan [AAA617] in combination with an androgen receptor pathway inhibitor
/
A Phase 1/2 Study of CLIO-8221 in Patients with Advanced Solid Tumors (NCT07300943)
A Phase 1/2 Study of CLIO-8221 in Patients with Advanced Solid Tumors (NCT07300943)
/
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma [DAWN-303] (NCT07522073)
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma [DAWN-303] (NCT07522073)
/
The effect of retrograde autologous priming on transfusion requirements after cardiac surgery [TheRAPy]: a multiple period vanguard cluster crossover trial – Australian arm (Trial Not Registered)
The effect of retrograde autologous priming on transfusion requirements after cardiac surgery [TheRAPy]: a multiple period vanguard cluster crossover trial – Australian arm (Trial Not Registered)
/
A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 48-week SAR448851 treatment followed by open-label extension in participants with early Alzheimer’s
A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of 48-week SAR448851 treatment followed by open-label extension in participants with early Alzheimer’s
/
A Phase Ib Dose Escalation/Dose Expansion Study of PTM-101 as an Adjunct to Neoadjuvant Therapy for Treatment Naïve, Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma [PDAC].
A Phase Ib Dose Escalation/Dose Expansion Study of PTM-101 as an Adjunct to Neoadjuvant Therapy for Treatment Naïve, Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma [PDAC].
/
Clinical Effectiveness of Ripretinib in Gastrointestinal Stromal Tumor [GIST]: Real-world Experience in Australia (Trial Not Registered)
Clinical Effectiveness of Ripretinib in Gastrointestinal Stromal Tumor [GIST]: Real-world Experience in Australia (Trial Not Registered)
/
Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double-Blind, Placebo-Controlled Study (NCT07499440)
Safety and Efficacy of HB-1 for PTSD: A Multi-center, Randomized, Double-Blind, Placebo-Controlled Study (NCT07499440)
/
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis (NCT06978725)
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis (NCT06978725)
/
A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin [CPUO] (NCT07700056)
A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin [CPUO] (NCT07700056)
/